C. Borges

Antiretroviral medication treatment for all HIV-infected individuals: a protocol using innovative multilevel methodologies to evaluate New York City's universal ART policy among problem substance users

D. D. Des Jarlais, M. Pavlicova, S. Braunstein, 2016, BMC Health Services Research.

Reasons for PrEP Discontinuation After Navigation at Sexual Health Clinics: Interactions Among Systemic Barriers, Behavioral Relevance, and Medication Concerns

T. Hedberg, S. Golub, J. Myers, 2022, Journal of acquired immune deficiency syndromes.

P428 HIV incidence, and pre- and post-exposure prophylaxis (PrEP and PEP) among PEP users at new york city sexual health clinics

S. Braunstein, S. Blank, D. Daskalakis, 2019, Poster Presentations.

HIV Treatment Knowledge in the Context of “Treatment as Prevention” (TasP)

S. Braunstein, S. Tross, A. Campbell, 2020, AIDS and Behavior.

The HIV Pre-exposure Prophylaxis (PrEP) cascade at NYC Sexual Health Clinics: Navigation is the Key to Uptake.

T. Hedberg, S. Blank, D. Daskalakis, 2020, Journal of acquired immune deficiency syndromes.

Durable Viral Suppression Among People with HIV and Problem Substance Use in the Era of Universal Antiretroviral Treatment

R. Remien, D. D. Des Jarlais, M. Pavlicova, 2021, AIDS and Behavior.

Health Care Provider Decisions to Initiate Oral HIV Preexposure Prophylaxis in New York City Public Sexual Health Clinics

C. Leu, J. Mantell, S. Hoffman, 2023, Sexually transmitted diseases.

Initiating antiretroviral treatment for newly diagnosed HIV patients in sexual health clinics greatly improves timeliness of viral suppression.

S. Braunstein, S. Blank, D. Daskalakis, 2021, AIDS (London).